About Arbutus
Specialized in virology. Focused on growth.
We are a clinical-stage biopharmaceutical company with deep virology expertise and an unwavering focus on curing a variety of conditions with unmet medical need. Today, we’re drawing upon our understanding and expertise in treating viral infections to develop and progress novel therapeutics focused on the areas of hepatitis B virus (HBV) and coronavirus.
Arbutus Bio At-a-Glance
Active Clinical Trials
3
Compounds in Development
5
PhDs / MDs
37
Focused On
HBV & coronaviruses
What makes us different?
Robust internal research capabilities.
Our deep competencies in internal research and development have yielded an impressive pace of innovation and a robust portfolio of assets for the treatment of diverse viral conditions.
Multi-faceted, unique mechanisms of action.
We are focused on the development of combination drugs to attack viruses through multiple mechanisms of action and significantly improve treatment options and outcomes for patients.
Active clinical and pre-clinical trials.
Our pipeline includes numerous clinical trials and pre-clinical studies spanning single and combination therapies, various conditions, and diverse routes.
Tenacious and highly experienced team.
The members of our leadership team have successful track records in the discovery, development, and commercialization of several widely recognized antivirals.
Why Arbutus?
The meaning behind our name.
Arbutus is a plant found throughout North America, where we are headquartered, that is known to have healing properties. Much like our botanical namesake, we are mutually focused on the growth of our portfolio of therapeutics and the healing of the patients who suffer from our targeted conditions.
